FOCL EDAP TMS S.A.

4.270USD+0.95%Mkt Cap: 201.62M $P/E: —

EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France…

Key Statistics

Company
Market Cap201.62M USD
Enterprise Value216.35M USD
Revenue (TTM)79.31M USD
Gross Profit30.00M USD
Net Income (TTM)-29.25M USD
Revenue/Share2.12 USD
Last Price4.270 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees289
CountryUS
SectorHealthcare
IndustryMedical Distribution
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.40
PEG—
EV/EBITDA-9.14
EV/Revenue2.73
P/S2.54
P/B-49.65
EPS (TTM)-1.40
EPS (Forward)-0.67
52W Range
1.75054% of range6.400
52W High6.400 USD
52W Low1.750 USD
Profitability
Gross Margin42.54%
Oper. Margin-60.83%
EBITDA Margin-29.85%
Profit Margin-41.47%
ROE-150.65%
ROA-37.02%
Growth
Revenue Growth38.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-16.41M USD
CapEx (TTM)5.76M USD
FCF Margin-16.07%
FCF Yield-6.32%
Net Debt20.14M USD
Net Debt/EBITDA-0.85
Balance Sheet
Debt/Equity1.43
Current Ratio1.60
Quick Ratio0.88
Book Value/Sh-0.09 USD
Cash/Share0.47 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)8.800 USD
Upside (mean)+106.1%
Target Range4.000 USD – 15.00 USD
4.000+106.1% to mean15.00
# Analysts5
Ownership
Shares Out.47.22M
Float36.25M
Insiders5.11%
Institutions31.33%
Short Interest
Short Ratio2.0d
Short % Float0.64%
Short % Out.0.52%
Shares Short245.66K
Short (prev mo.)195.16K
Technical
SMA 504.722 (-9.6%)
SMA 2004.342 (-1.7%)
Beta-0.05
S&P 52W Chg16.45%
Avg Vol (30d)103.28K
Avg Vol (10d)79.52K
Technical Indicators
RSI (14)43.2
MACD-0.0950
MACD Signal-0.1158
MACD Hist.+0.0208
BB Upper4.727 USD
BB Middle4.313 USD
BB Lower3.899 USD
BB Width19.20%
ATR (14)0.2615 USD
Vol Ratio (20d)0.06x